Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in axial spondyloarthropathy
2005-001202-60Phase 4Active
- Sponsor
- Organisation name was not entered
- Start
- Apr 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of methotrexate in axial spondyloarthritis (axSpA) and ankylosing spondylitis (AS), sponsored by Organisation name was not entered. Primary endpoint: ASAS20 response. Started Apr 2005; status: active.
02
Drugs
methotrexate
03
Conditions
axial spondyloarthritis (axSpA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2005-001202-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001202-60.